Anti-CGRP mAbs for the Preventive Treatment of Migraine: An Overview Review and a Cost Saving Analysis in the Global Scenario

Zovi, A; Lasala, R; Ferrara, F; Langella, R; Vitiello, A; Sabbatucci, M; Musazzi, UM

Zovi, A (通讯作者),Univ Camerino, Sch Pharm, Via Sant Agostino 1, I-62032 Camerino, Italy.

HOSPITAL PHARMACY, 2023; ():

Abstract

Objectives: Migraine is a neurological disease with a high frequency of incidence. The new monoclonal antibodies selective for the calcitonin gene-rel......

Full Text Link